Table 2.
Prevalence of nausea in acute (day 1) and delayed phases (day 2-3).
| Number of patients (%)** |
Response* | |||||
|---|---|---|---|---|---|---|
| Day 3 |
Day 2 |
Day 1 |
||||
| Placebo | Ginger | Placebo | Ginger | Placebo | Ginger | |
| 18 (50%) | 19 (53%) | 17 (47%) | 20 (55.5%) | 15 (42%) | 19 (53%) | Control |
| 18 (50%) | 17 (47%) | 19 (53%) | 16 (44.5%) | 21 (58%) | 17 (47%) | No control |
*Absence and presence of nausea was defined as control and no control. **McNemar’s test compared between ginger and placebo groups. p- value in day 1 = 0.388, in day 2 = 0.508 and in day 3 < 0.999.